Home
Subscribers
Back Issues
Search
.
Columns
Law Pubs
- Entertainment Law Digest
- Securities Law Review

Prescription Drugs

October 1, 2018October 1, 2018 ROBERT KAHN

Brief7, pharmaceuticals, SEC

MANHATTAN — The SEC brought federal complaints against Salix Pharmaceuticals and its CFO Adam Derbyshire , claiming they lied about stuffing supply chains for their drugs, and when sales predictably dropped, the share price dropped by 34 percent.

Click to share on Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
Click to share on Google+ (Opens in new window)

Like this:

Like Loading...

Related

← Data Leak
Specialty Drugs →

CNS Trends

KFC Franchisee Loses Fight to Market Chicken as Muslim-Friendly
California Trashes Thousands of Mail-In Ballots, ACLU Says
Experts Say Negotiation in Khashoggi Case Trumps Investigation
Leaked Memo Advises Silence on Fish & Wildlife Info Requests
California Gets Six New Appeals Court Judges
Jurors Defend $289 Million Roundup Cancer Verdict
Mueller Pushes Back at Russian Firm's Bid to Wriggle Out of Charges
Judge Slashes Punitive Damages in Roundup Cancer Case
Lawsuit Seeks to Stop the Sale of Wild Horses for Slaughter

Columns
Law
National
Regional
International
About Us
Terms of Use
Privacy Policy

Copyright © 2018 . All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.

%d bloggers like this: